Main menu

Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Possible Combination With AstraZeneca

Monday, April 28, 2014 - 7:00am
EDT

 

Pfizer Inc. will hold analyst and investor calls to discuss its continuing interest in a possible merger transaction with AstraZeneca Plc. at 8:30 AM EDT (1:30 PM GMT) today, April 28, 2014.

Pfizer will also hold a media call at 10:00 AM EDT (3:00 PM GMT) today, April 28, 2014.

The information to access the calls can be found below.

INVESTOR / ANALYST CALL
April 28, 2014
8:30 AM EDT / 1:30 PM GMT

Participant Dial in:
International direct: (706) 634-2365
US Toll free: (866) 246-2545
Password: Pfizer Meeting 2

Webcast link: http://www.visualwebcaster.com/event.asp?id=99132

Replay:
International direct: (404) 537-3406
US Toll free: (855) 859-2056
Conference ID: 36646191

MEDIA CALL
April 28, 2014
10:00 AM EDT / 3:00 PM GMT

Participant Dial in:
International direct: (706) 634-2365
US Toll free: (866) 246-2545
UK Toll free: (800) 028-8438
Password: Pfizer Meeting 3

Webcast linkhttp://www.visualwebcaster.com/event.asp?id=99134                            

For more information, please visit http://www.Pfizerupdate.com.

Contact: 

Pfizer Inc.

Media Relations:

Joan Campion, 212-733-2798

Andrew Topen, 212-733-1338

or

Investor Relations:

Ryan Crowe, 212-733-8160